UPB
Upstream Bio Inc
NASDAQ · Biotechnology
$26.20
+0.20 (+0.77%)
Open$26.56
Previous Close$26.00
Day High$27.98
Day Low$25.94
52W High$33.68
52W Low$5.14
Volume—
Avg Volume656.7K
Market Cap1.42B
P/E Ratio—
EPS$-2.29
SectorBiotechnology
Analyst Ratings
Strong Buy
12 analysts
Price Target
-5.8% upside
Current
$26.20
$26.20
Target
$24.68
$24.68
$18.50
$24.68 avg
$35.72
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 2.50M | 198.99M | 177.59M |
| Net Income | -66,105,404 | -4,151,490 | -3,219,143 |
| Profit Margin | -2,650.0% | -2.1% | -1.8% |
| EBITDA | -78,772,049 | -5,330,036 | -5,179,349 |
| Free Cash Flow | — | -2,620,505 | -3,332,995 |
| Rev Growth | — | +14.1% | -5.8% |
| Debt/Equity | — | 0.66 | 0.62 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $223.43 | +2.01% | 165.4 | 394.89B |
| AMGN | Amgen Inc | $384.32 | +4.49% | 26.8 | 206.95B |
| GILD | Gilead Sciences Inc | $152.50 | +2.10% | 23.3 | 189.20B |
| VRTX | Vertex Pharmaceuticals Inc | $477.92 | +4.17% | 33.7 | 123.82B |
| REGN | Regeneron Pharmaceuticals | $785.51 | +2.46% | 18.4 | 83.03B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.16 | -0.93% | 995.2 | 43.35B |